Promoter holding
64.27%
EP
Excel Pharmaceuticals Private Limited - Due diligence report
A 360° intelligence report on Excel Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, grow…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Excel Pharmaceuticals Private Limited — 360° Intelligence Report
Generated from MCA filings & public records68/100
Trust Score
Moderate
Excel Pharmaceuticals Private Limited is assessed as Moderate with a Trust Score of 68/100. Excel Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 1973, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 10 Aug 2026 from the latest processed filings. Excel Pharmaceuticals Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
33/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 1.42).
- Profitable - internal accruals available.
Charges position: 3 open (1.02 cr) · 8 satisfied (1.71 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Bassein Catholic Co-Operative Bank Limited | 4 | 48.0 cr |
| Others | 1 | 48.0 cr |
| The Bassein Catholic Co-Operative Bank Limited | 1 | 48.0 cr |
| Punjab National Bank | 2 | 48.0 cr |
| Canara Bank | 3 | 48.0 cr |
Compliance Score: 33/100 Caution Indicated
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BANKS, MCA.
- Litigation present in 1 court forum(s).
- 1 auditor resignation(s) filed - latest: B J RAUT & CO on 2022-05-15.
- 1 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| BIJAYKUMAR BANKEBIHARI GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUDHA GUPTA BIJAY KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- BIJAYKUMAR BANKEBIHARI GUPTA has DIN status "Disqualified by RoC u/s 164(2)".
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 53+ years.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (33/100).
3 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence61/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment73/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 1.02 cr already registered.
- Compliance gaps should be priced into terms.
Investor view88/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
06 Aug 2025
Charge satisfied
The Bassein Catholic Co-Operative Bank Limited
04 Aug 2025
Charge created
Others - 94.40 Lakh
29 Jul 2025
Charge satisfied
Bassein Catholic Co-Operative Bank Limited
31 Mar 2025
Latest balance sheet
Filed with ROC
17 Nov 2023
Director appointed
SUDHA GUPTA BIJAY KUMAR (Additional Director)
Director ceased
LAL BANSHI DEVI
09 Jan 2023
Director ceased
SHIVJEE GUPTA
20 Dec 2022
Charge satisfied
Canara Bank
25 Mar 2022
Charge satisfied
Bassein Catholic Co-Operative Bank Limited
18 Feb 2021
Director ceased
SUDHA GUPTA BIJAY KUMAR
05 Jun 2013
Director ceased
KIRAN KARSANLAL CHOKSI
Director ceased
DEVAYANI KIRAN CHOKSI
10 Jan 2012
Charge created
Bassein Catholic Co-Operative Bank Limited - 35.00 Lakh
31 Dec 2011
Charge created
Bassein Catholic Co-Operative Bank Limited - 35.00 Lakh
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Astus Hybrid Seeds Private Limited | U01403UP2016PTC077354 | Varanasi, Uttar Pradesh, India |
| Ostrich Pharmaceuticals Private Limited | U74900DL2011PTC227898 | New Delhi, Delhi, India |
| Ecountry Private Limited | U72900WB2016PTC216894 | Kolkata, West Bengal, India |
| Babulnath Alloys Private Limited | U27106GJ2004PTC044859 | Bhavnagar, Gujarat, India |
| Atmanirbhar Shetkari Producer Company Limited | U01100MH2020PTC342625 | Jalgaon, Maharashtra, India |
| Fairdeal Diesels Private Limited | U23201RJ1997PTC013941 | Alwar, Rajasthan, India |
| Vitalys Pharmaceuticals Private Limited | U24232PB2014PTC038951 | Jalandhar, Punjab, India |
| Rosava Workspace Private Limited | U74999RJ2016PTC054930 | Udaipur, Rajasthan, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Excel Pharmaceuticals Private Limited before audits and certifications: compliance score 33/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Excel Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Excel Pharmaceuticals Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Excel Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Excel Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Excel Pharmaceuticals Private Limited an active company?
Excel Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 33/100 (Caution Indicated).
Is Excel Pharmaceuticals Private Limited financially healthy?
Excel Pharmaceuticals Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Excel Pharmaceuticals Private Limited?
Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Excel Pharmaceuticals Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Excel Pharmaceuticals Private Limited have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.
Is Excel Pharmaceuticals Private Limited up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 33/100 (Caution Indicated).
Is it risky to lend to Excel Pharmaceuticals Private Limited?
Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
